There are no solutions. There are only trade-offs.
This is spot on. I presented at the Interdisciplinary Conference on Psychedelic Research in 2016 on this exact topic: https://www.youtube.com/watch?v=ZFvIIB5EgJ4 We are one high profile overdose or one bad clinical trial away from federal panic, the rollback of norms, and thousands losing their liberties. The stepwise, measured approach is critical. Without it, we're one bad batch of psychedelic therapists away from this vanishing for another 50 years.
I propose that Business/Money is as important as any of the other movements. Look at "New Approach" and the millions of dollars being poured into the State Initiative movements. Look at all the decriminalization movements State wide and all the money being raised to support those efforts. Look at Atai, Compass Pathways, MindMed, Usona etc etc that suck millions of dollars of donations annually. Look at all the Psychedelic Therapy and Facilitator training companies that now exist. In the end I contend the Business/Money side of the movement controls the narrative, has the political voice that speaks the loudest and will in the end decide how this "Psychedelic Renaissance" plays out. Until the Scientific, Political and Cultural communities understand the power the Business/Money movement hold the outcomes will be driven by money. As usual.
just a history correction: first psychedelic clinical trials after the pause were at University of New Mexico (Rick Strassman, MD administering IV DMT to human subjects and Francis Moreno, MD administering psilocybin in an OCD trial)
Thoughtful and thought provoking, Zach - thank you for addressing.